Prellis Bio's Externalized Human Immune System ™ rapidly generates 300 SARS-CoV2 antibodies

(Krause Taylor Associates) Prellis has generated 300 human IgG antibodies that bind to either the S1 or S2 spike protein of the SARS-CoV2-Wuhan strain of the novel coronavirus. The company produced 960 synthetic human lymph nodes that were challenged with a SARS-CoV2 vaccine-like cocktail, leading to virus-specific antibody generation. The process doesn't require an infected donor, extensive screening or generation of antibodies in animals, reducing the time to produce a targeted library of candidate antibodies to less than one month.
Source: EurekAlert! - Biology - Category: Biology Source Type: news